Abstract:The retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs), including RIG-I and melanoma differentiation-associated gene 5 (MDA5), sense cytoplasmic viral RNA and initiate innate antiviral responses. How RIG-I and MDA5 are differentially regulated remains enigmatic. In this study, we identified the guanylate-binding protein (GBP) and zinc-finger FYVE domain-containing protein ZFYVE1 as a negative regulator of MDA5- but not RIG-I-mediated innate antiviral responses. ZFYVE1-deficiency promoted MDA5- but not RIG-I-mediated transcription of downstream antiviral genes. Comparing to wild-type mice, Zfyve1(-/-) mice were significantly protected from lethality induced by encephalomyocarditis virus (EMCV) that is sensed by MDA5, whereas Zfyve1(-/-) and Zfyve1(+/+) mice were comparable to death induced by vesicular stomatitis virus (VSV) that is sensed by RIG-I. Mechanistically, ZFYVE1 interacted with MDA5 but not RIG-I. ZFYVE1 bound to viral RNA and decreased the ligand binding and oligomerization of MDA5. These findings suggest that ZFYVE1 acts as a specific negative regulator of MDA5-mediated innate immune responses by inhibiting its ligand binding and oligomerization. Author summary RIG-I and MDA5 are the main cytosolic sensors for invaded viral RNA. How these sensors are differentially regulated is largely unknown. In this study, we identified ZFYVE1 as a specific regulator of MDA5- but not RIG-I-mediated antiviral responses. ZFYVE1-deficiency promotes antiviral immune responses and renders the mice less susceptible to EMCV-induced death. ZFYVE1 interacts with MDA5 and viral dsRNA, and inhibits the ligand binding and oligomerization of MDA5. Our study reveals a negative regulatory mechanism for keeping MDA5 inactive in un-infected cells, which contributes to our understanding on how innate antiviral responses are delicately regulated to avoid immune damage.

MLL5 Suppresses Antiviral Innate Immune Response by Facilitating STUB1-mediated RIG-I Degradation

SIRT5 Impairs Aggregation and Activation of the Signaling Adaptor MAVS Through Catalyzing Lysine Desuccinylation

The Ubiquitin Ligase RNF5 Regulates Antiviral Responses by Mediating Degradation of the Adaptor Protein MITA

Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation.

The RNA-binding protein LUC7L2 mediates MITA/STING intron retention to negatively regulate innate antiviral response

UBR5 promotes antiviral immunity by disengaging the transcriptional brake on RIG-I like receptors

Cyclin-dependent kinase 5 negatively regulates antiviral immune response by disrupting myeloid differentiation primary response protein 88 self-association

MLL1 is Regulated by KSHV LANA and is Important for Virus Latency

E3 Ligase FBXW7 is Critical for RIG-I Stabilization During Antiviral Responses

OTUD5 Promotes Innate Antiviral and Antitumor Immunity Through Deubiquitinating and Stabilizing STING

The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I.

RNF5: inhibiting antiviral immunity and shaping virus life cycle

ZFYVE1 negatively regulates MDA5-but not RIG-I-mediated innate antiviral response

Dual modifying of MAVS at lysine 7 by SIRT3-catalyzed deacetylation and SIRT5-catalyzed desuccinylation orchestrates antiviral innate immunity

Lsm14a Plays A Critical Role in Antiviral Immune Responses by Regulating Mita Level in A Cell-Specific Manner

KAP1-Mediated Epigenetic Suppression in Anti-RNA Viral Responses by Direct Targeting RIG-I and MDA5

LTN1 promotes RLR degradation to inhibit immune response to RNA virus through the ESCRT pathway

Ttll12 Inhibits the Activation of Cellular Antiviral Signaling Through Interaction with Visa/Mavs

The RNA helicase DDX5 promotes viral infection via regulating N6-methyladenosine levels on the DHX58 and NFκB transcripts to dampen antiviral innate immunity

Trim65-Catalized Ubiquitination is Essential for Mda5-Mediated Antiviral Innate Immunity

Negative Regulation of RNF90 on RNA Virus-Triggered Antiviral Immune Responses Targeting MAVS